FIELD: medicine, pharmaceutics.SUBSTANCE: group of inventions refers to biotechnology. What is presented is a probiotic composition containing a probiotic ingredient, which is presented by Bifidobacterium longum R175 and one or two bacterial species specified in a group consisting of Lactobacillus rhamnosus R11, Lactobacillus helveticus R52 and Lactobacillus plantarum R1012, and a carrier composition. The above carrier composition contains mixture of prebiotics containing inulin and fructose, lactoferrin, inorganic salts, and glutathione as possible. There are also presented versions of the compositions in certain ratio of the above ingredients. What is also presented is a version of the composition containing mixture of probiotic ingredients consisting of Bifidobacterium longum R175 and Lactobacillus rhamnosus R11, a prebiotic ingredient, lacroferrin, inorganic salts and Saccharomyces boulardii. The above compositions are used for supporting and/or recovering the intestinal health and for preventing disbiosis of any origin in mammals, as well as in a method for improving a survival rate of the bacteria Bifidobacterium longum in the gastrointestinal tract.EFFECT: group of inventions provides the effective colonisation of the gastrointestinal tract with the probiotic ingredients, causes the accompanying anti-inflammatory and immunomodulatory action.20 cl, 4 tbl, 4 exГруппа изобретений относится к биотехнологии. Предложена пробиотическая композиция, содержащая пробиотический компонент, в качестве которого используют Bifidobacterium longum R175 и один или два вида бактерий, выбранных из группы бактерий, состоящей из Lactobacillus rhamnosus R11, Lactobacillus helveticus R52 и Lactobacillus plantarum R1012, и композицию-носитель. Указанная композиция-носитель содержит смесь пребиотиков, содержащую инулин и фруктозу, лактоферрин, неорганические соли, и возможно глутатион. Предложены также варианты композиции при определенном содержании перечисленных компонентов. Предло